Beth A. Weaver, PhD

Position title: Associate Professor, Department of Oncology/McArdle Laboratory for Cancer Research

Email: baweaver@wisc.edu

Phone: 608-263-5309

Address:
6109 WIMR
1111 Highland Ave

Lab Website
Weaver Lab
Beth Weaver

Research Interests

  • Chromosome segregation during mitosis
  • Effects of chromosome segregation missegregation on tumor initiation, progression, and response to therapy
  • Mitotic errors induced by chemotherapy and radiation

Honors & Awards

  • 2017-2018 UWCCC Ride Scholar
  • 2017-2022 Romnes Faculty Fellow
  • 2015-2019 American Cancer Society Research Scholar
  • 2010 American Cancer Society University of Wisconsin Institutional Research Grant Award
  • 2006-2008 Postdoctoral Fellowship, Philip Morris Foundation
  • 2006 Brigid G. Leventhal Scholar in Cancer Research Award
  • 1999-2002 National Cancer Institute Training Grant

Selected Publications

For a full list, visit Dr. Weaver’s PubMed page

  • Burkard M.E. and Weaver B.A. 2017. Tuning chromosomal instability to optimize tumor fitness. Cancer Discov 7: 134-136.
  • Choudhary A., Zachek B., Lera R.F., Zasadil L.M., Lasek A., Denu R.A., Kim H., Kanugh C., Laffin J., Harter J.M., Wisinski K.B., Saha S., Weaver B.A., Burkard M.E. 2016. Identification of selective lead compounds for treatment of high-ploidy breast cancer. Mol Cancer Ther. 15:48-59.
  • Denu R.A., Zasadil L.M., Kanugh C., Laffin J., Weaver B.A., Burkard M.E. 2016. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. BMC Cancer Jan 29;16:47.
  • Zasadil L.M., Britigan E.M.C., Ryan S.D., Kaur C., Guckenberger D.J., Beebe, D.J., Moser A.R., Weaver B.A. 2016. High rates of chromosome missegregation suppress tumor progression, but do not inhibit tumor initiation. Mol Biol Cell 27: 1981-9. This work was highlighted on the cover of the issue and by the American Society for Cell Biology.
  • Cunningham C.E., Li S., Vizeacoumar F.S., Bhanumathy K.K., Lee J.S., Parameswaran S., Furber L., Abuhussein O., Paul J.M., McDonald M., Templeton S.D., Shukla H., El Zawily A.M., Boyd F., Alli N., Mousseau D.D., Geyer R., Bonham K., Anderson D.H., Yan J., Yu-Lee L.Y., Weaver B.A., Uppalapati M., Ruppin E., Sablina A., Freywald A. Vizeacoumar F.J. 2016. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget 7:61544-61561.
  • Funk L.C., Zasadil L.M., Weaver B.A. 2016. Living in CIN: Mitotic infidelity and its consequences for tumor promotion and suppression. Dev Cell 39: 638-652.
  • Hwang B, McCool K, Wan J, Wuerzberger-Davis SM, Young EW, Choi EY, Cingolani G, Weaver BA, Miyamoto S. IPO3 mediated nonclassical nuclear import of NEMO drives DNA damage-dependent NF-κB activation. J Biol Chem. 2015 Jun 9. pii: jbc.M115.645960.
  • Zasadil LM, Andersen K, Ryan SD, Yeum D, Raines R, Burkard ME, and Weaver BA (2014). Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Science Translational Medicine 6:229ra43. (This work was selected for F1000 Prime and highlighted on the cover of the issue, in Science News and in Cancer Discovery News.
  • Weaver, B.A. 2014. How Taxol/paclitaxel kills cancer cells. Mol Biol Cell 25:2677-81.
  • Britigan, E.M.C., Wan, J., Zasadil, L.M., Ryan, S.D. and Weaver, B.A.  2014. The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B. Mol Biol Cell 25:2761-73. (This work was highlighted by the American Society for Cell Biology)
  • Wan, J., Zhu, F., Zasadil, L.M., Yu, J., Wang, L., Johnson, A., Berthier, E., Beebe, D.J., Audhya A. and Weaver, B. A. 2014. Golgi localized pool of the mitotic checkpoint component Mad1 controls integrin secretion and cell migration, Curr Biol 24: 2687–2692. (This work was highlighted in Science Signaling.)